The role of COPD and inhaled corticosteroids in major adverse cardiovascular events in cardiovascular-kidney-metabolic populations
Anne E Ioannides(Imperial College London), Jennifer K. Quint(London Biofoundry), Emily L. Graul(Emory University), Upasana Tayal(University of Leeds), Constantinos Kallis(Imperial College London), Hana Mullerova(AstraZeneca (France))
Cited by 1
Related Papers
Titin-truncating variants affect heart function in disease cohorts and the general population
|Nature Genetics|2016|367
Genetic Variants Associated With Cancer Therapy–Induced Cardiomyopathy
|Circulation|2019|346
Genetic Etiology for Alcohol-Induced Cardiac Toxicity
|Journal of the American College of Cardiology|2018|300
Temporal Risk of Nonfatal Cardiovascular Events After Chronic Obstructive Pulmonary Disease Exacerbation: A Population-based Study
|American Journal of Respiratory and Critical Care Medicine|2023|79